158 related articles for article (PubMed ID: 37753690)
1. A single-center, randomized, controlled study on the efficacy of niacinamide-containing body emollients combined with cleansing gel in the treatment of mild atopic dermatitis.
Zhu JR; Wang J; Wang SS
Skin Res Technol; 2023 Sep; 29(9):e13475. PubMed ID: 37753690
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ
Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005
[TBL] [Abstract][Full Text] [Related]
3. [Clinical observation on the efficacy and safety of dupilumab in the treatment of moderate to severe atopic dermatitis].
Li CY; Chen S; Qian WL; Yang L; Zheng Q; Chen AJ; Chen J; Huang K; Fang S; Wang P; Hu L; Liu XR; Zhao XQ; Tan N; Cai T
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1590-1595. PubMed ID: 37859375
[TBL] [Abstract][Full Text] [Related]
4. Validation of five patient-reported outcomes for atopic dermatitis severity in adults.
Silverberg JI; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Ong PY; Fuxench ZC; Simpson EL
Br J Dermatol; 2020 Jan; 182(1):104-111. PubMed ID: 30972740
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial.
Magnolo N; Jaenicke T; Tsianakas A; Czech W; Thaçi D; Pinter A; Kerob D; Salah S; Luger TA
J Eur Acad Dermatol Venereol; 2023 Jun; 37 Suppl 5():18-26. PubMed ID: 37092275
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled, double-blind, randomized, prospective study of a glycerol-based emollient on eczematous skin in atopic dermatitis: biophysical and clinical evaluation.
Breternitz M; Kowatzki D; Langenauer M; Elsner P; Fluhr JW
Skin Pharmacol Physiol; 2008; 21(1):39-45. PubMed ID: 18025807
[TBL] [Abstract][Full Text] [Related]
7. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.
Hon KL; Pong NH; Wang SS; Lee VW; Luk NM; Leung TF
Drugs R D; 2013 Mar; 13(1):37-42. PubMed ID: 23456759
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
9. Individual Article: A Novel 3-Step Over-the-Counter Eczema Regimen Improves Eczema Severity, Itch, and Life Quality: Randomized Study.
Hawley K; Lio P; Nguyen T; Qureshi A; Emesiani C; Meckfessel M
J Drugs Dermatol; 2023 Oct; 22(10):SF388641s21-SF388641s26. PubMed ID: 37801543
[TBL] [Abstract][Full Text] [Related]
10. Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
Danby SG; Andrew PV; Taylor RN; Kay LJ; Chittock J; Pinnock A; Ulhaq I; Fasth A; Carlander K; Holm T; Cork MJ
Clin Exp Dermatol; 2022 Jun; 47(6):1154-1164. PubMed ID: 35167133
[TBL] [Abstract][Full Text] [Related]
11. Hygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settings.
Cowdell F; Jadotte YT; Ersser SJ; Danby S; Lawton S; Roberts A; Dyson J
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011377. PubMed ID: 32006460
[TBL] [Abstract][Full Text] [Related]
12. Impact of daily use of emollient 'plus' on corticosteroid consumption in patients with atopic dermatitis: An open, randomized controlled study.
Zelenkova H; Kerob D; Salah S; Demessant-Flavigny AL
J Eur Acad Dermatol Venereol; 2023 Jun; 37 Suppl 5():27-34. PubMed ID: 37092256
[TBL] [Abstract][Full Text] [Related]
13. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study.
Tiplica GS; Boralevi F; Konno P; Malinauskiene L; Kaszuba A; Laurens C; Saint-Aroman M; Delarue A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1180-1187. PubMed ID: 29419920
[TBL] [Abstract][Full Text] [Related]
14. Testing an Ectoin Containing Emollient for Atopic Dermatitis.
Hon KL; Kung JS; Ng WGG; Leung TF
Curr Pediatr Rev; 2019; 15(3):191-195. PubMed ID: 30987568
[TBL] [Abstract][Full Text] [Related]
15. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
Iannone M; Tonini G; Janowska A; Dini V; Romanelli M
Curr Med Res Opin; 2021 Aug; 37(8):1295-1301. PubMed ID: 34027753
[TBL] [Abstract][Full Text] [Related]
16. Clinical and instrumental evaluation of the efficacy of an emollient cream and a cleansing cream in the management of mild to moderate adulthood atopic dermatitis.
Cristaudo A; Lupi F; Mariano M; Cianchini G; De Rocco M; De Pità O
G Ital Dermatol Venereol; 2018 Dec; 153(6):855-859. PubMed ID: 30518177
[TBL] [Abstract][Full Text] [Related]
17. Individual Article: Efficacy of Over-The-Counter Cream in Reducing Eczema Signs.
Hebert AA; Grivet-Seyve M; Anjuwon S; Piccardi N; Lachmann N; Cruz A; Emesiani C
J Drugs Dermatol; 2023 Oct; 22(10):SF388641s5-SF388641s9. PubMed ID: 37801541
[TBL] [Abstract][Full Text] [Related]
18. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis.
Diluvio L; Dattola A; Cannizzaro MV; Franceschini C; Bianchi L
G Ital Dermatol Venereol; 2019 Feb; 154(1):32-36. PubMed ID: 30207438
[TBL] [Abstract][Full Text] [Related]
19. Atopic Dermatitis in Children in the General Population: Baseline Characteristics, Medication Use, and Severity Measures in the Rotterdam Eczema Study.
van Halewijn KF; van der Most F; Bohnen AM; Pasmans SGMA; Bindels PJE; Elshout G
Dermatitis; 2024; 35(1):61-69. PubMed ID: 37015063
[No Abstract] [Full Text] [Related]
20. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
